Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02800304
Other study ID # 20590
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 1, 2015
Est. completion date March 31, 2017

Study information

Verified date February 2019
Source University of Waterloo
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

M2E is a developmental evaluation of the implementation of the Integrated Nutrition Pathway for Acute Care, in five medical units in five hospitals in Canada.


Recruitment information / eligibility

Status Completed
Enrollment 5995
Est. completion date March 31, 2017
Est. primary completion date March 31, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- admitted to study unit

- no delirium or dementia

- return to community anticipated

Exclusion Criteria:

- unable to communicate in English or French

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Canada Royal Alexander Hospital Edmonton Alberta
Canada Niagara Health Systems Niagara Falls Ontario
Canada The Ottawa Hospital Ottawa Ontario
Canada Pasqua Hospital Regina Saskatchewan
Canada Concordia Hospital Winnipeg Manitoba

Sponsors (2)

Lead Sponsor Collaborator
University of Waterloo University of Western Ontario, Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Implementation success of Integrated Nutrition Pathway for Acute Care (INPAC) INPAC is an evidence based pathway to improve detection, prevention and treatment of malnutrition in acute care. The primary outcome of this study is the trajectory and proportion of care activities that happen for a given population e.g. % screened, assessed with SGA, have standard care strategies provided etc. admission